2026 International Congress of Diabetes and Metabolism(1일차)

세부 일정 (51강)

• 14:30~14:45 Telemedicine regulation in Korea: principles and directions Room 2 권용진(서울의대 서울대병원)
• 14:45~15:00 Safety concerns in telemedicine and the role of KDA practice standards Room 2 김진숙(대한의사협회 의료정책연구원)
• 15:00~15:15 Structuring telemedicine guidance for diabetes: an endocrinologist Room 2 김헌성(가톨릭의대 내과)
• 15:15~15:30 Panel discussion Room 2 한정훈 선재원 백종하 김명진(대구프렌닥터한내과의원 나만의닥터 경상의대 내과 한림의대 내과)
• 14:30~14:50 Establishing pancreatic endocrine dysfunction as an internal organ disability: background and criteria Room 3 김재현(서울의대 소아청소년과)
• 14:50~15:10 Quality of life and social challenges following registration as a person with a disability Room 3 김경미(숭실대 사회복지학과)
• 15:10~15:30 Panel discussion Room 3 박유정 김준영(안산대 사회복지학과 한림대의료원 동탄성심병원)
• 14:30~15:00 Heterogeneity of clinical-pathological trajectories in DKD Room 4 문주영(경희의대)
• 15:00~15:30 Decoding DKD heterogeneity: clinical pharmacological approaches to bridge renal injury and long-term outcomes Room 4 Hiddo Lambers Heerspink(University Medical Center Groningen)
• 14:30~14:50 Plasma and extracellular vesicle multi-omics responses to single bout of resistance and endurance exercise in humans Room 5 이현승(충남의대 내과)
• 14:50~15:10 Aging reshapes sex- and diet-specific metabolic plasticity across the adipose–liver–muscle axis Room 5 오창명(GIST )
• 15:10~15:30 Spatially resolved metabolic flux modeling of liver tissue: integrating transcriptomics, metabolomics, and metallomics via genome-scale constraint-based modeling Room 5 Cheng Zhang(KCL UK)
• 14:30~14:45 Metabolic aging and insulin resistance: mechanistic overlap in older adults Room 6 최종한(건국의대 내과)
• 14:45~15:00 Sarcopenia and type 2 diabetes in older adults: pathophysiological mechanisms and therapeutic strategies Room 6 정혜수(한림의대 내과)
• 15:00~15:15 Chronic kidney disease in older adults with diabetes: clinical and pathophysiological perspectives Room 6 노은(서울의대 내과)
• 15:15~15:30 Panel discussion Room 6 전성완 유성훈 배재현(포항세명기독병원 내과 한양의대 내과 한림의대 내과)
• 15:30~15:40 휴식 ( )
• 15:40~16:00 Updates in CGM interpretation: from core metrics and AGP to GMI–A1C discordance Room 2 진상만(성균관의대 내과)
• 16:00~16:20 Results from the first clinical trial of a stage 5 connected insulin pen Room 2 김지윤(성균관의대 내과)
• 16:20~16:40 Pathways to fully automated insulin delivery: scientific feasibility and remaining barriers Room 2 John Shin(MiniMed)
• 15:40~16:00 Noninvasive imaging for MASLD: from transient elastography to magnetic resonance imaging Room 3 Wah-Kheong Chan(University of Malaya)
• 16:00~16:20 Blood-based biomarkers and scores: practical approaches to fibrosis assessment Room 3 이혜원(연세의대 내과)
• 16:20~16:40 Future directions in MASLD diagnostics: AI, radiomics, and multi-omics approaches Room 3 Terry Cheuk Yip(The Chinese University of Hong Kong)
• 15:40~16:00 Compensatory signatures of β-cells and islet stellate cells in human obesity Room 4 김현기(KAIST)
• 16:00~16:20 An unbiased drug screen to identify agents that reverse β-cell dedifferentiation Room 4 Jinsook Son(Cornell University)
• 16:20~16:40 Impact of type 2 diabetes-associated PAX4 variant on pancreatic beta cell function Room 4 문준호(서울의대 내과)
• 15:40~15:55 Microvascular angiopathy and mitochondrial dysfunction: the pivotal drivers of diabetic nerve damage and therapeutic targets Room 5 김수경(경상의대 내과)
• 15:55~16:10 The search for biomarkers for early prediction of diabetic peripheral neuropathy Room 5 조호찬(계명의대 내과)
• 16:10~16:25 Epigenetic regulation of diabetic neuropathy Room 5 Ji Hu(Soochow University)
• 16:25~16:40 Panel discussion Room 5 김지민 이경애 김종화(세종충남대병원 전북의대 내과 부천세종병원 내과)
• 15:40~16:00 Impact of GDM on mother and offspring Room 6 Ronald Ma(The Chinese University of Hong Kong)
• 16:00~16:20 Early GDM consensus statement Room 6 Viswanathan Mohan(Madras Diabetes Research Foundation)
• 16:20~16:40 The emerging role of CGM in gestational diabetes: evidence and future directions Room 6 최훈지(동탄성심병원)
• 16:40~16:50 휴식 ( )
• 16:50~17:05 Early initiation of CGM and AID in T1D Room 2 Viral N Shah(Indiana University)
• 17:05~17:20 The gap beyond the AGP: translating patterns into prescribing decisions in T2D and prediabetes Room 2 유승현(가톨릭관동의대 내과)
• 17:20~17:35 Diabetes technology from a patient Room 2 Noriko Kodani(National Center for Global Health and Medicine)
• 17:35~17:50 Panel discussion Room 2 양여리 문선준 홍준화(가톨릭의대 내과 성균관의대 내과 을지의대 내과)
• 16:50~17:05 The efficacy and safety of CU01-1001 in subjects with diabetic kidney disease (DKD) Room 3 원규장(영남의대 내과)
• 17:05~17:20 Vanoglipel, the most advanced GPR119 agonist for MASH Room 3 김미경(동아ST)
• 17:20~17:35 Targeting hepatic enzymes as a strategy to suppress MASH Room 3 송재환(연세대 생화학과)
• 17:35~17:50 Panel discussion Room 3 임승순 김주연 하은영(계명의대 생리학교실 한양대 에리카 분자의약 계명의대 내과)
• 16:50~17:10 NT-proBNP as a biomarker of cardiometabolic risk: global evidence and emerging perspectives Room 4 Ronald Ma(The Chinese University of Hong Kong)
• 17:10~17:30 Integrating NT-proBNP into diabetes care: implications for cardio-renal protection strategies Room 4 전자영(아주의대 내과)
• 17:30~17:50 NT-proBNP in the early detection and management of heart failure in patients with type 2 diabetes Room 4 조동혁(고려의대 심장내과)
• 16:50~17:10 Genetic basis of type 1 diabetes and utility of genetic risk scores across diverse genetic ancestries Room 5 Stephen S. Rich(University of Virginia)
• 17:10~17:30 Polygenic risk scores and heterogeneity of metabolic disease Room 5 김대은(서울의대)
• 17:30~17:50 Biobank studies for diabetes in East Asia Room 5 Wayne H-H Sheu(National Health Research Institutes)
• 16:50~17:10 From cohort to national infrastructure: multi-center CDM-based AI for predicting diabetic complications Room 6 이상열(경희의대 내과)
• 17:10~17:30 Reshaping diabetes care with AI prognostic management and prescription digital therapeutics Room 6 황보율(국립암센터)
• 17:30~17:50 Panel discussion Room 6 이승희 차효성 임유리 박태현(국립보건연구원 위뉴 에비드넷 오디엔)